Home
Home

lung cancer

Scrappy Upstarts Aiming For Pfizer's Xalkori Market

Scrappy Upstarts Aiming For Pfizer's Xalkori Market
Seeking Alpha

Sanofi Ends Iniparib Research, Plans $285 Million Charge

Sanofi Ends Iniparib Research, Plans $285 Million Charge
Bloomberg

Synta's Lung Cancer Drug Struggles to Remain Relevant

Synta's Lung Cancer Drug Struggles to Remain Relevant
TheStreet.com

Encouraging News for Peregrine Pharma

Encouraging News for Peregrine Pharma
Yahoo/Zacks

Bristol Myers Squibb And The New Wave Of Cancer Drugs

Bristol Myers Squibb And The New Wave Of Cancer Drugs
Seeking Alpha

Peregrine Pharma agrees with FDA on lung cancer trial design

Peregrine Pharma agrees with FDA on lung cancer trial design
Reuters

Merck KGaA Doesn’t Rule Out Pursuing Lung-Cancer Vaccine

Merck KGaA Doesn’t Rule Out Pursuing Lung-Cancer Vaccine
Bloomberg

ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine

ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine
TheStreet.com

Roche immunotherapy shows response over range of cancers

Roche immunotherapy shows response over range of cancers
Reuters

Novartis Boost Seen in Fast Approvals as Protection Ends

Novartis Boost Seen in Fast Approvals as Protection Ends
Bloomberg